Q3 EPS Estimates for CVS Health Increased by Leerink Partnrs

CVS Health Corporation (NYSE:CVS) – Research analysts at Leerink Partnrs upped their Q3 2025 earnings estimates for shares of CVS Health in a report issued on Thursday, October 16th. Leerink Partnrs analyst M. Cherny now anticipates that the pharmacy operator will post earnings per share of $1.35 for the quarter, up from their prior forecast of $1.34. The consensus estimate for CVS Health’s current full-year earnings is $5.89 per share. Leerink Partnrs also issued estimates for CVS Health’s Q4 2025 earnings at $0.99 EPS.

Other equities analysts have also recently issued research reports about the stock. Zacks Research cut shares of CVS Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 8th. Morgan Stanley increased their price objective on shares of CVS Health from $82.00 to $89.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 14th. Leerink Partners increased their price objective on shares of CVS Health from $86.00 to $95.00 and gave the stock an “outperform” rating in a research report on Thursday, October 16th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of CVS Health in a research report on Tuesday, October 14th. Finally, Wolfe Research increased their price objective on shares of CVS Health from $80.00 to $85.00 and gave the stock an “outperform” rating in a research report on Monday, September 22nd. Two research analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $82.57.

CVS Health Stock Down 0.1%

Shares of NYSE CVS opened at $82.47 on Monday. The company has a 50 day simple moving average of $74.35 and a 200-day simple moving average of $68.25. The company has a market capitalization of $104.59 billion, a P/E ratio of 23.04, a P/E/G ratio of 0.91 and a beta of 0.60. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.80 and a quick ratio of 0.62. CVS Health has a 1 year low of $43.56 and a 1 year high of $82.88.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.46 by $0.35. The business had revenue of $98.92 billion during the quarter, compared to the consensus estimate of $94.87 billion. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The business’s revenue was up 8.4% compared to the same quarter last year. During the same quarter last year, the firm earned $1.83 EPS. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, November 3rd. Shareholders of record on Thursday, October 23rd will be given a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 3.2%. The ex-dividend date of this dividend is Thursday, October 23rd. CVS Health’s dividend payout ratio (DPR) is currently 74.30%.

Insider Buying and Selling

In other news, Director Anne A. Finucane sold 7,500 shares of CVS Health stock in a transaction on Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total transaction of $532,650.00. Following the completion of the sale, the director directly owned 22,156 shares of the company’s stock, valued at approximately $1,573,519.12. The trade was a 25.29% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 1.22% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On CVS Health

Institutional investors have recently modified their holdings of the company. Harbor Capital Advisors Inc. lifted its position in shares of CVS Health by 72.1% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 142 shares during the last quarter. Avion Wealth lifted its position in shares of CVS Health by 99.0% during the 2nd quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 189 shares during the last quarter. Harbor Asset Planning Inc. purchased a new stake in shares of CVS Health during the 2nd quarter worth $30,000. Bell Investment Advisors Inc lifted its position in shares of CVS Health by 119.8% during the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock worth $31,000 after purchasing an additional 248 shares during the last quarter. Finally, Front Row Advisors LLC lifted its position in shares of CVS Health by 436.5% during the 2nd quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock worth $31,000 after purchasing an additional 371 shares during the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.